Investor Relations | YKNOT
logo
En
  • En
  • Gr
  • Overview
  • Share Price
    • Year 2026
    • Year 2025
    • Year 2024
    • Year 2023
    • Year 2022
    • Year 2021
    • Year 2020
  • Shareholders
    • Shareholding
    • Shareholders Rights
  • Financials
    • Group & Parent Company
    • Subsidiaries
  • Governance
    • Members of the BoD
    • Policy on the Suitability of Members of the BoD
    • Remuneration Policy of the BoD
    • Remuneration Report of the BoD
      • Year 2025
      • Year 2024
      • Year 2023
      • Year 2022
      • Year 2021
      • Year 2020
      • Year 2019
    • Members of the Audit Committee
    • Regulation of Operation of the Audit Committee
    • Activity Report of the Audit Committee
      • Year 2025
      • Year 2024
      • Year 2023
      • Year 2022
      • Year 2021
      • Year 2020
      • Year 2019
    • Members of the Remuneration & Nominations Committee
    • Regulation of Operation of the Remuneration and Nominations Committee
    • Organization Structure
    • Equity Participations
    • Articles of Association
    • HCG Code
  • Corporate News
    • Year 2026
    • Year 2025
    • Year 2024
    • Year 2023
    • Year 2022
    • Year 2021
    • Year 2020
  • Contact IR
  • Home
  • Ελληνικά
En
  • En
  • Gr
Shareholders Rights
Proposals upon all issues of the agenda of the Ordinary General Meeting of the 16th July 2026
25/06/2026 by IR in Shareholders Rights

Proposals upon all issues of the agenda of the Ordinary General Meeting of the 16th July 2026

ITEM 1: Submission and approval of the Annual Separate and Consolidated Financial Statements for the financial year 1.1–31.12.2025, the relevant Annual Management Report of the Board of Directors and the Independent Certified Auditor’s Audit Report thereon.

The Board of Directors recommends to the General Meeting the approval of the Annual Separate and Consolidated Financial Statements for the financial year 1.1–31.12.2025, together with the relevant Reports and Statements of the Board of Directors and the Certified Auditor’s Audit Report thereon, as approved by the Board of Directors at its meeting of 30.4.2026, published in accordance with the law and available on the Company’s website www.yknot.gr under Financial Information / Group and Parent Company / Financial Statements.

ITEM 2: Approval of the overall management carried out during the financial year 1.1–31.12.2025 pursuant to article 108 of Law 4548/2018 and discharge of the Certified Auditor from any liability pursuant to article 117 of Law 4548/2018.

Following approval of the Annual Financial Statements, the Ordinary General Meeting is invited to approve the overall management of the Company by the Board of Directors and to resolve on the discharge of the Certified Auditor from any liability for damages for the financial year 1.1–31.12.2025.

ITEM 3: Election of an audit firm for the audit of the financial year 2026 and determination of its remuneration.

Following the relevant recommendation of the Company’s Audit Committee, the Board of Directors unanimously proposes the audit firm “BDO Certified Auditors S.A.” (SOEL Reg. No. 173) as auditor for the financial year 1.1.2026–31.12.2026. The audit fee for 2026 shall be determined by decision of Management in accordance with the audit data. For this purpose, it is proposed that the Board of Directors be authorized to conduct the relevant negotiation and to send the written notice-instruction to the elected audit firm within the prescribed deadline. Finally, it is proposed that the fee of EUR 27.500 plus VAT paid to the same audit firm for the statutory audit for 2025 be approved.

ITEM 4: Submission for discussion and advisory vote of the Remuneration Report for the financial year 2025, pursuant to article 112 of Law 4548/2018.

Following a recommendation of the Company’s Remuneration and Nomination Committee, the Board of Directors approved, at its meeting of 30.04.2026, the Remuneration Report for the financial year 2025 and resolved to submit it to the Ordinary General Meeting for discussion in accordance with article 112 of Law 4548/2018. The shareholders’ vote on this item is advisory in nature. The total remuneration received by the members of the Board of Directors during 2025 complies with the Remuneration Policy approved by the Ordinary General Meeting of 10.07.2025 and the Extraordinary General Meeting of 4.11.2025. The Remuneration Report is incorporated in the Corporate Governance Statement, which forms part of the Board of Directors’ Management Report for 2025, is available on the Company’s website www.yknot.gr under Financial Information / Group and Parent Company / Financial Statements, as well as under Management, and will remain available on the corporate website for a period of ten (10) years, as provided by law. The Remuneration Report for 2025 and the detailed information contained therein have been audited and confirmed by the Certified Auditor in accordance with article 112 par. 4 of Law 4548/2018.

ITEM 5: Revision of the existing Remuneration Policy – Approval of a new Remuneration Policy pursuant to articles 110 and 111 of Law 4548/2018.

Pursuant to article 110 par. 2 item c of Law 4548/2018, companies are required to submit the Remuneration Policy for approval by the General Meeting whenever there is a material change in the circumstances under which the approved Remuneration Policy was prepared. The Company’s current Remuneration Policy was approved by resolution of the Extraordinary General Meeting of 4.11.2025. However, by its relevant resolution dated 24.6.2025, the Board of Directors now recommends to the General Meeting that the Company’s Remuneration Policy be revised so that it no longer requires executive members of the Board of Directors to be linked to the Company by a remunerated mandate relationship, nor to describe in detail the terms of any such agreements.

Accordingly, it is proposed that the relevant paragraph of article 3(c) be deleted, as its content does not directly concern the Remuneration Policy but rather matters relating to the legal nature of the relationship between the executive members of the Board of Directors and the Company and the specific terms of their individual agreements. In particular, the reference to the remunerated mandate relationship, the duration of agreements, termination terms, description of duties, confidentiality obligations and avoidance of conflicts of interest concerns corporate governance, company law and contractual matters, which are determined by the relevant decisions of the competent corporate bodies and the individual agreements of the members of the Board of Directors.

Maintaining such references in the Remuneration Policy does not add material information as to the principles, structure and criteria for determining remuneration, while it may create unnecessary restrictions or the need to revise the Policy in the event of changes to the contractual terms or type of cooperation relationship of specific members of the Board of Directors with the Company. For reasons of clarity, flexibility and focus on the subject matter required by Law 4548/2018 for the Remuneration Policy, it is considered appropriate to delete the said paragraph.

Finally, for the avoidance of doubt, it is proposed that paragraphs (e) and (g) of article 3 of the Remuneration Policy be reworded so that it is absolutely clear that the capacity of Chair of the Audit Committee and Chair of the Remuneration and Nomination Committee entails remuneration of six thousand euros (EUR 6.000) and three thousand euros (EUR 3.000), respectively, in addition to the remuneration determined by virtue of membership of those Committees. Therefore, the revision and approval of a new Remuneration Policy by the convened annual Ordinary General Meeting of 16 July 2026 is required by law. The proposed revised Remuneration Policy of the Company is available in draft form on the Company’s website www.yknot.gr under Shareholders’ Rights / Information.

ITEM 6: Announcement of the election of a new member of the Board of Directors in replacement of a resigned member, pursuant to the resolution of the Board of Directors dated 23.6.2026, or election of another person to that position for the period until the expiry of the term of office of the Board of Directors, pursuant to article 82 par. 1 of Law 4548/2018 and article 11 par. 4 of the Articles of Association regarding the Board of Directors.

1.BACKGROUND AND APPLICABLE LEGAL FRAMEWORK

On 22.6.2026, the independent non-executive member of the Board of Directors, Calliope Papadopoulou, submitted her resignation and, at its meeting of 23.6.2026, the Board of Directors elected Ms. Vasiliki Andreadi, of Dimitrios, as a new independent non-executive member of the Board of Directors in replacement of the resigned member. The term of office of the new member was set for the remaining period until completion of the term of office of the Board, namely four years from the date of its election by the Ordinary General Meeting of 10.7.2025, automatically extendable until the expiry of the deadline within which the Ordinary General Meeting for the year 2029 must convene and until the relevant resolution is adopted. The acts of the above elected members are deemed valid during the period between her election and any replacement by the convened annual Ordinary General Meeting.

The election of the above new member of the Board of Directors in replacement of the resigned member was made in accordance with the recommendation dated 23.6.2026 of the Remuneration and Nomination Committee, which proposed her election and established that she meets the suitability criteria in accordance with the Company’s Suitability Policy, its Rules of Operation and the specific provisions of article 3 of Law 4706/2020 on corporate governance, as in force.

In accordance with the law and article 11 par. 4 of the Articles of Association, the above resolution of the Board of Directors on the election of a new member in replacement of the resigned member (Board minutes no. 650) has been submitted to the publicity formalities required by law, while the curriculum vitae of the new Board member and the full text of the relevant recommendation of the Remuneration and Nomination Committee have also been posted on the Company’s website.

As a result, at the same meeting of 23.6.2026 (minutes no. 650), the Board of Directors was constituted as follows:

1.Rigas Tzortzis, Chair, non-executive member,

  1. Georgios Koutsos, executive member, Chief Executive Officer and deputy of the Chair in relation to his non-executive duties,
  2. Ioannis Mouzakis, Deputy Chief Executive Officer, executive member,
  3. Panagiotis Tzortzis, non-executive member,
  4. Christina Korkidi, independent non-executive member,
  5. Vasiliki Andreadi, independent non-executive member.

Following the above, the resolution of the Board of Directors dated 23.6.2026 on the election of a new member in replacement of the resigned member is announced for approval to the convened annual Ordinary General Meeting of shareholders of 16.7.2026, which may either approve the above election or elect another person as member of the Board of Directors for the period until the expiry of the term of office of the existing Board of Directors, which has been set at four years as above.

2.PROPOSAL OF THE BOARD OF DIRECTORS AND CONFIRMATION OF SUITABILITY CRITERIA

The Board of Directors naturally proposes to the convened annual Ordinary General Meeting of shareholders of 16.7.2026 not to elect another person in the place of the above elected Vasiliki Andreadi and to approve her election as member of the Board of Directors in accordance with the resolution of the Board of Directors dated 23.6.2026 (Board minutes no. 650). In this context, it informs the General Meeting that the Remuneration and Nominations Committee confirmed that, with the election of Ms. Vasiliki Andreadi in replacement of Ms. Calliope Papadopoulou, all requirements and provisions of Law 4706/2020 on adequate gender representation on the Board of Directors and the legally required number of independent non-executive members are fully met, no impediments under article 3 par. 4 of Law 4706/2020 apply to Ms. Andreadi the Board members continue to possess the necessary training, skills, moral standing, reputation, integrity, independence of judgement and experience; and no impediment, incompatibility or conflict of interest exists in relation to Ms. Andreadi.

At the same meeting on 23.6.2026, the Remuneration and Nominations Committee also established that the new member of the Board of Directors, Vasiliki Andreadi, possesses the necessary elements required by the Company’s Suitability Policy, namely professional training, experience, adequate knowledge and skills, moral standing and reputation, independence of judgement, absence of conflict of interest and the ability to devote sufficient time to the performance of her duties. In addition to Ms. Andreadi’s individual suitability, the Committee also established that, at collective level, following her election, the members of the Board of Directors, through their combination and diversity of knowledge, experience, backgrounds and gender, meet the criterion of collective suitability within the meaning of the Company’s Suitability Policy.

ITEM 7: Announcement of the election of a new member of the Audit Committee in replacement of a resigned member, pursuant to the resolution of the Board of Directors dated 23.6.2026, or election of another person to that position for the period until the expiry of the term of office of the Board of Directors, pursuant to article 44 par. 1(f) of Law 4449/2017.

The Chair of the Audit Committee, Ms. Calliope Papadopoulou, resigned with effect from 22.6.2026 and, at its meeting of 23.6.2026, the Board of Directors appointed Ms. Vasiliki Andreadi, of Dimitrios, as a new member of the Audit Committee in replacement of the resigned member. By the same resolution, the Audit Committee appointed Ms. Vasiliki Andreadi as its Chair, in accordance with article 44 par. 1(e) of Law 4449/2017, as in force, and was constituted as follows:

– Vasiliki Andreadi, independent non-executive Board member, Chair,

– Christina Korkidi, independent non-executive Board member, Member,

– Rigas Tzortzis, Chair and non-executive Board member, Member.

Accordingly, the Audit Committee retains its composition required by law, consisting of three (3) non-executive Board members, of whom two (2) are independent non-executive members. The term of office of the Audit Committee has been set equal to the term of office of the Board of Directors, namely four years from the date of its election on 10.7.2025, automatically extendable until the expiry of the deadline within which the Ordinary General Meeting for the year 2029 must convene and until the relevant resolution is adopted.

Pursuant to article 44 par. 1(f) of Law 4449/2017, the convened annual Ordinary General Meeting of 16.7.2026 may either approve the election of Ms. Vasiliki Andreadi as Chair of the Audit Committee or elect another person for the period until the expiry of its term of office. The Board of Directors naturally proposes that the General Meeting does not elect another person in her place and approves her election as Chair of the Audit Committee by virtue of the resolution of the Board of Directors dated 23.6.2026. This proposal is submitted following the recommendation of the Remuneration and Nominations Committee dated 23.06.2026, according to which the requirements of article 44 of Law 4449/2017 regarding the composition of the Audit Committee are fully met.

ITEM 8: Approval of remuneration and other benefits paid to the members of the Board of Directors during the financial year 2025, determination of their amount for the financial year 2026 and advance payment thereof until the Ordinary General Meeting of 2027, pursuant to article 109 of Law 4548/2018.

Following a recommendation of the Company’s Remuneration and Nomination Committee, the Board of Directors proposes that the General Meeting approve the total remuneration, expenses and all kinds of compensation paid during 2025 to its members for the performance of their duties, in accordance with the resolution of the Ordinary General Meeting dated 10.07.2025 and the applicable Remuneration Policy, as set out in the table below:

Full Name/ Title BoD Fees (€) Audit Committee Fees (€) Remuneration & Nominations Committee Fees (€) Salary (€) Benefits (€) Total 2025 (€)
Outgoing Members
Theofanis Kiriacoulis (CEO until 31/10) 41.644  – – 6.303 47.947
Spyridon Kiriacoulis (Chairman until 06/06) 26.469  – – 888 27.357
Charikleia Theodorou (Exec. Member until 06/06) –  – 27.988 6.052 34.040
New Members (from reconstitution)
Rigas Tzortzis (Chairman of the BoD) 11.986 2.877 1.438 – – 16.301
Georgios Koutsos (CEO) 23.973 – – – – 23.973
Ioannis Mouzakis (Deputy CEO) 23.973 – – – – 23.973
Calliope Papadopoulou (Independent Non-Exec. Member) 4.795 5.754 2.877 – – 13.425
Christina Korkidi (Independent Non-Exec. Member) 4.795 2.877 1.438 – – 9.110
Panagiotis Tzortzis (Non-Exec. Member) 1.699 – – – – 1.699

 

B. Furthermore, and following the recommendation of the Company’s Remuneration & Nominations Committee, the Board of Directors proposes to the General Meeting to approve the payment of the total remuneration, general expenses, and compensation of any nature to its members for the performance of their duties during the current financial year 2026, as these fees had been pre-approved by the decision of the Annual General Meeting dated 10.07.2025 (with the exception of the remuneration of Mr. Panagiotis Tzortzis, whose election took place subsequently, via the Board of Directors’ decision dated 3.11.2025, and was approved by the Extraordinary General Meeting on 4.11.2025 in accordance with Article 82, paragraph 1 of Law 4548/2018). In all cases, the remuneration paid is compliant with the applicable Remuneration Policy, as follows:

(a) regarding Georgios Koutsos, it is proposed to approve the payment of remuneration amounting to fifty thousand euros (€50.000) per annum, pro rata for the period from 1.1.2026 to 16.7.2026,

(b) regarding Ioannis Mouzakis, it is proposed to approve the payment of remuneration amounting to fifty thousand euros (€50.000) per annum, pro rata for the period from 1.1.2026 to 16.7.2026,

(c) regarding Rigas Tzortzis, it is proposed to approve the payment of remuneration amounting to thirty-four thousand euros (€34.000) per annum, pro rata for the period from 1.1.2026 to 16.7.2026,

(d) regarding Panagiotis Tzortzis, it is proposed to approve the payment of remuneration amounting to ten thousand euros (€10.000) per annum, pro rata for the period from 1.1.2026 to 16.7.2026,

(e) regarding Christina Korkidi, it is proposed to approve the payment of remuneration amounting to nineteen thousand euros (€19.000) per annum, pro rata for the period from 1.1.2026 to 16.7.2026, and

(f) regarding Kalliopi Papadopoulou, it is proposed to approve the payment of remuneration amounting to twenty-eight thousand euros (€28.000) per annum, pro rata for the period from 1.1.2026 to 22.6.2026, the date on which she tendered her resignation as an independent non-executive member of the Board of Directors and Chair of the Audit Committee and the Remuneration & Nominations Committee.

C. Additionaly, the General Meeting is invited to determine the amount of remuneration and other benefits to the members of the Board of Directors, in accordance with the Law, the newly proposed for approval Remuneration Policy of the Company, and the Articles of Association, during the current financial year and until the Annual General Meeting of the year 2026, pursuant to the specific provisions of Article 109 of Law 4548/2018.

Specifically, the following remunerations are proposed:

(a) regarding Georgios Koutsos, it is proposed to pre-approve remuneration amounting to fifty thousand euros (€50.000) per annum, pro rata for the period from 16.7.2026 onwards, and for as long as he retains the capacity of executive member of the Board of Directors,

(b) regarding Ioannis Mouzakis, it is proposed to pre-approve remuneration amounting to fifty thousand euros (€50.000) per annum, pro rata for the period from 16.7.2026 onwards, and for as long as he retains the capacity of executive member of the Board of Directors,

(c) regarding Rigas Tzortzis, it is proposed to pre-approve remuneration (i) amounting to twenty-five thousand euros (€25.000) per annum, pro rata for the period from 16.7.2026 onwards, and for as long as he retains the capacity of Chairman of the Board of Directors, (ii) an additional six thousand euros (€6.000) per annum, pro rata for the period from 16.7.2026 onwards, and for as long as he retains the capacity of member of the Audit Committee, and (iii) an additional three thousand euros (€3.000) per annum, pro rata for the period from 16.7.2026 onwards, and for as long as he retains the capacity of member of the Remuneration & Nominations Committee, i.e., a total of thirty-four thousand euros (€34.000) per annum, pro rata for the period from 16.7.2026 onwards, and for as long as he retains each of the aforementioned capacities,

(d) regarding Panagiotis Tzortzis, it is proposed to pre-approve remuneration amounting to ten thousand euros (€10.000) per annum, pro rata for the period from 16.7.2026 onwards, and for as long as he retains the capacity of non-executive member of the Board of Directors,

(e) regarding Christina Korkidi, it is proposed to pre-approve remuneration (i) amounting to ten thousand euros (€10.000) per annum, pro rata for the period from 16.7.2026 onwards, and for as long as she retains the capacity of independent non-executive member of the Board of Directors, (ii) an additional six thousand euros (€6.000) per annum, pro rata for the period from 16.7.2026 onwards, and for as long as she retains the capacity of member of the Audit Committee thereof, and (iii) an additional three thousand euros (€3.000) per annum, pro rata for the period from 16.7.2025 onwards, and for as long as she retains the capacity of member of the Remuneration & Nominations Committee, i.e., a total of nineteen thousand euros (€19.000) per annum, from 16.7.2026 onwards, and for as long as she retains each of the aforementioned capacities, and

(f) regarding Vasiliki Andreadi, it is proposed to pre-approve remuneration (i) amounting to ten thousand euros (€10.000) per annum, pro rata for the period from 23.6.2026 onwards, and for as long as she retains the capacity of independent non-executive member of the Board of Directors, (ii) an additional twelve thousand euros (€12.000) per annum, pro rata for the period from 23.6.2026 onwards, and for as long as she retains the capacity of Chair of the Audit Committee, and (iii) an additional six thousand euros (€6.000) per annum, pro rata for the period from 23.6.2026 onwards, and for as long as she retains the capacity of Chair of the Remuneration & Nominations Committee, i.e., a total of twenty-eight thousand euros (€28.000) per annum, from 23.6.2026 onwards, and for as long as she retains each of the aforementioned capacities.

Finally, it is proposed to pre-approve the payment of various travel, transport, and representation expenses in general to members of the Board of Directors (such as mobile telephony expenses, any mandatory insurance contributions, the use of Company cars and the payment of their operating expenses) during the current financial year 2026 and until the Annual General Meeting of the year 2027. The relevant amounts will be included in the Remuneration Report of the members of the Board of Directors for the financial year 2026, which will be disclosed to the shareholders in accordance with the law.”

ITEM 9: Granting permission to the members of the Board of Directors and the Company’s directors, pursuant to article 98 of Law 4548/2018, to participate in boards of directors or in the management of other companies belonging to the Company’s Group and pursuing similar or related purposes.

The Board of Directors recommends that permission be granted, pursuant to article 98 par. 1 of Law 4548/2018, to the members of the Board of Directors and the Company’s senior executives to participate in Boards of Directors or in the management of companies belonging to the Company’s group and pursuing similar or related purposes, as well as to participate as general partners, sole shareholders or partners in the above companies.

ITEM 10: Submission of the Audit Committee Activity Report for the financial year 2025 pursuant to article 44 of Law 4449/2017 and of the Report of the Independent Non-Executive Members of the Board of Directors pursuant to article 9 of Law 4706/2020.

Pursuant to article 44 par. 1(i) of Law 4449/2017, as in force, the Company’s Audit Committee submits to the annual Ordinary General Meeting the Activity Report for 2025, which is incorporated in the Corporate Governance Statement, forms part of the Board of Directors’ Management Report for 2025 and is available on the Company’s website www.yknot.gr under Financial Information / Group and Parent Company / Financial Statements, as well as under Management.

Pursuant to article 9 par. 5 of Law 4706/2020, the Report of the Independent Non-Executive Members of the Board of Directors for 2025 is also submitted for the information of the General Meeting and is available on the Company’s website under Shareholders’ Rights.

This item does not require a resolution and is not put to a vote.

ITEM 11: Granting authorization to the Board of Directors to increase the Company’s share capital in accordance with article 24 par. 1 item b of Law 4548/2018 and article 7 of the Articles of Association, and to restrict or exclude pre-emptive rights in accordance with article 27 par. 4 of Law 4548/2018.

The Board of Directors recommends that the General Meeting grant to the Board of Directors, pursuant to article 24 par. 1 item b of Law 4548/2018 and article 7 of the Articles of Association, for a period of five (5) years from the date of the resolution of the convened annual Ordinary General Meeting, the authority to resolve upon an increase of the Company’s share capital by an amount not exceeding three times the paid-up share capital existing on that date, namely up to EUR 68,356,440 in nominal capital, through the issuance of new common registered voting shares, as well as the authority to restrict or exclude pre-emptive rights in the context of such share capital increase, pursuant to article 27 par. 4 of Law 4548/2018, and generally to carry out every necessary or appropriate act for the implementation of the increase, including the relevant amendment of the Company’s Articles of Association.

The proposed authorization is considered necessary for the Company to maintain the required flexibility, considering the particularities of the shipping sector and the dynamics of the international markets in which it operates. The ability to raise capital quickly may support the timely exploitation of investment opportunities, renewal or strengthening of the fleet and enhancement of the Company’s capital structure under conditions of volatility in freight and financing markets. The authorization does not entail a share capital increase but enables the Board of Directors, if it deems it appropriate and in the corporate interest, to decide on such an increase within the limits set by the General Meeting and in accordance with applicable law and the Articles of Association.

Furthermore, granting to the Board of Directors the authority to exclude or restrict pre-emptive rights facilitates the entry of strategic and/or institutional investors who may materially contribute to strengthening the Company’s capital base and supporting its long-term growth strategy, while also enhancing access to international capital markets. In any event, the exercise of this authority by the Board of Directors is subject to the strict condition that it serves the corporate interest and takes place in accordance with the principles of transparency, sound management and equal treatment of shareholders. The Board of Directors will specifically and adequately justify each decision to restrict or exclude pre-emptive rights.

ITEM 12: Amendment of the Share Buyback Program.

By resolution of the Extraordinary General Meeting of shareholders dated 4.11.2025, a Share Buyback Program was established pursuant to article 49 of Law 4548/2018 and the Board of Directors was authorized to take all required actions for its implementation. Under the relevant terms of the Program, the maximum number of shares that the Company could acquire was existing common registered shares issued by the Company, corresponding to up to 10% of its paid share capital, namely 759.516 shares. The same provision was maintained in the resolution of the Board of Directors dated 06/05/2026 which resolved on the commencement of the Program.

In this respect, the Board of Directors recommends to the General Meeting that the Company be able to acquire own shares under the Program up to 10% of the Company’s paid-up share capital from time to time. Determining the maximum limit by reference to the Company’s paid-up capital from time to time, rather than the paid-up capital on the date of the relevant resolution of the Extraordinary General Meeting of 4.11.2025, is consistent with article 49 par. 2 item a of Law 4548/2018 and is considered necessary in order to ensure the operational effectiveness of the Program throughout its duration and until its expiry on 3/11/2027.

The Company’s capital structure may change during the term of the Program, indicatively due to share capital increases, corporate actions or other changes in the number of shares. Linking the maximum limit to the total number of shares from time to time ensures that the buyback program remains proportional and compatible with the Company’s shareholder base at any time, avoiding distortions that could arise from subsequent corporate actions. This arrangement also enhances the flexibility of the Program, enabling the Board of Directors to implement it in a manner consistent with market conditions and the Company’s capital management strategy, to the benefit of the Company and its shareholders.

Following the above, the characteristics of the proposed amended Share Buyback Program are as follows: maximum number of shares: existing common registered shares issued by the Company corresponding to up to 10% of its paid-up share capital from time to time; duration of the Program: 24 months from the day following the Extraordinary General Meeting of shareholders of 4.11.2025; purchase price range: between EUR 0.60 minimum, equal to the nominal value of the share, and EUR 8.00 maximum per own share; financing of the Program: exclusively through free cash flows and other available funds of the Company.

The Program is proposed to be established for the pursuit and implementation of any lawful purpose, including the free allocation of shares to members of the Board of Directors and persons connected with the Company by an employment relationship who provide services to the Company on a regular basis, as well as to its affiliated companies within the meaning of article 32 of Law 4308/2014, and in accordance with the applicable legislative and regulatory framework, including articles 49 and 50 of Law 4548/2018, Regulation (EU) No 596/2014 on market abuse and Commission Delegated Regulation (EU) 2016/1052.

Accordingly, the General Meeting of shareholders is invited to approve the amendment of the Program as set out above and to authorize the Board of Directors of the Company to take all required actions for the implementation of the above.

ITEM 13: Miscellaneous announcements.

This item includes announcements on matters that the Board of Directors wishes to bring to the attention of the Meeting, but which do not require the adoption of a resolution and are not put to a vote.

 

IR

Shareholders

  • Shareholding
  • Shareholders Rights

Quick Links

  • The Firm
  • What We Do
  • News & Insights
  • Investor Relations
  • Careers

Social

  • LinkedIn

Get in Touch

  • Contact Us
  • Privacy Policy
© Υ/ΚΝΟΤ INVEST S.A.
logo